Construction of HSV-1 HF based replication defective vector

被引:0
|
作者
Xiang, Li [1 ]
Liu, Xinjing [1 ]
Liu, Huitao [1 ]
Han, Zhiqiang [1 ]
Lu, Jiameng [1 ]
Xu, Yuming [1 ]
机构
[1] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China
关键词
HSV-1; homologous recombination; replication defective vectors; SIMPLEX-VIRUS TYPE-1; DELETION MUTANTS; INFECTION; ICP27;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Due to the unique biological features of original virus, HSV-1 derived vectors are rendered a number of advantages, such as broad cell tropism, including infection non-dividing mammalian cells across a broad range of species, and large capacity for foreign gene delivery. To date, two types of recombinant HSV-1 vectors known as replication competent vector and replication defective vector, derived from different HSV-1 strains, such as strain KOS and strain 17 have been developed as gene delivery vehicles and applied in fundamental studies and clinical trials for gene therapy. However, so far, no HSV-1-HF strain derived recombinant vector has been reported yet. Since the features of HSV-1 vectors are largely associated their original virus strains, the HSV-1 vectors from different strains may vary in their infection ability, tropism and cytotoxicity. Here, we described the construction of a HSV-1-HF strain based replication defective vector by a homologous recombination approach in bacteria. [Li Xiang, Xinjing Liu, Huitao Liu, Zhiqiang Han, Jiameng Lu and Yuming Xu. Construction of HSV-1 HF based replication defective vector. Life Science Journal. 2011; 8(3):547-553] (ISSN: 1097-8135). http://www.lifesciencesite.com.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 50 条
  • [21] Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread
    Valimaa, Hannamari
    Tenovuo, Jorma
    Waris, Matti
    Hukkanen, Veijo
    VIROLOGY JOURNAL, 2009, 6
  • [22] Inhibition of HSV-1 replication by a gene editing strategy
    Bellizzi, Anna
    Wollebo, Hassen S.
    Caocci, Maurizio
    De Chiara, Giovanna
    Palamara, Anna T.
    Gordon, Jennifer
    Khalili, Kamel
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S5 - S5
  • [23] Deciphering AAV replication strategy in the presence of HSV-1
    Nicolas, A.
    Alazard-Dany, N.
    Biollay, C.
    Arata, L.
    Jolinon, N.
    Kuhn, L.
    Ferro, M.
    Weller, S. K.
    Epstein, A. L.
    Greco, A.
    Salvetti, A.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1397 - 1397
  • [24] Inhibition of HSV-1 replication by a gene editing strategy
    Bellizzi, Anna
    Roehm, Pamela C.
    Shekarabi, Masoud
    Wollebo, Hassen S.
    Ibba, Gabriele
    White, Martyn K.
    He, Lifan
    Salkind, Julian
    Khalili, Kamel
    JOURNAL OF NEUROVIROLOGY, 2016, 22 : S7 - S8
  • [25] Development of replication - Conditional HSV-1 as glioma therapy
    Brown, S. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 6 - 7
  • [26] Inhibition of HSV-1 Replication by Gene Editing Strategy
    Pamela C. Roehm
    Masoud Shekarabi
    Hassen S. Wollebo
    Anna Bellizzi
    Lifan He
    Julian Salkind
    Kamel Khalili
    Scientific Reports, 6
  • [27] Inhibition of HSV-1 Replication by Gene Editing Strategy
    Roehm, Pamela C.
    Shekarabi, Masoud
    Wollebo, Hassen S.
    Bellizzi, Anna
    He, Lifan
    Salkind, Julian
    Khalili, Kamel
    SCIENTIFIC REPORTS, 2016, 6
  • [28] INFLUENCE OF THE HELPER VIRUS ON EXPRESSION OF BETA-GALACTOSIDASE FROM A DEFECTIVE HSV-1 VECTOR, PHSVLAC
    GELLER, AI
    JOURNAL OF VIROLOGICAL METHODS, 1991, 31 (2-3) : 229 - 238
  • [29] EFFECT OF RECOMBINANT SALIVARY CYSTATIN ON HSV-1 REPLICATION
    WEAVER, TR
    BERGEY, EJ
    LEVINE, MJ
    BOBEK, LA
    JOURNAL OF DENTAL RESEARCH, 1995, 74 : 84 - 84
  • [30] RAPID AND STABLE GENE-EXPRESSION IN HIPPOCAMPAL SLICE CULTURES FROM A DEFECTIVE HSV-1 VECTOR
    BAHR, BA
    NEVE, RL
    SHARP, J
    GELLER, AI
    LYNCH, G
    MOLECULAR BRAIN RESEARCH, 1994, 26 (1-2): : 277 - 285